Affordable Access

Access to the full text

The influence of healthcare financing on cardiovascular disease prevention in people living with HIV

Authors
  • Webel, Allison R.1
  • Schexnayder, Julie1
  • Rentrope, C. Robin1
  • Bosworth, Hayden B.2
  • Hileman, Corrilynn O.3, 4
  • Okeke, Nwora Lance2
  • Vedanthan, Rajesh5
  • Longenecker, Chris T.3
  • 1 Case Western Reserve University, Cleveland, OH, USA , Cleveland (United States)
  • 2 Duke University School of Medicine, Durham, NC, USA , Durham (United States)
  • 3 Case Western Reserve University School of Medicine, Cleveland, OH, USA , Cleveland (United States)
  • 4 The MetroHealth System, Cleveland, OH, USA , Cleveland (United States)
  • 5 New York University Grossman School of Medicine, New York, NY, USA , New York (United States)
Type
Published Article
Journal
BMC Public Health
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Nov 23, 2020
Volume
20
Issue
1
Identifiers
DOI: 10.1186/s12889-020-09896-8
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundPeople living with HIV are diagnosed with age-related chronic health conditions, including cardiovascular disease, at higher than expected rates. Medical management of these chronic health conditions frequently occur in HIV specialty clinics by providers trained in general internal medicine, family medicine, or infectious disease. In recent years, changes in the healthcare financing for people living with HIV in the U.S. has been dynamic due to changes in the Affordable Care Act. There is little evidence examining how healthcare financing characteristics shape primary and secondary cardiovascular disease prevention among people living with HIV. Our objective was to examine the perspectives of people living with HIV and their healthcare providers on how healthcare financing influences cardiovascular disease prevention.MethodsAs part of the EXTRA-CVD study, we conducted in-depth, semi-structured interviews with 51 people living with HIV and 34 multidisciplinary healthcare providers and at three U.S. HIV clinics in Ohio and North Carolina from October 2018 to March 2019. Thematic analysis using Template Analysis techniques was used to examine healthcare financing barriers and enablers of cardiovascular disease prevention in people living with HIV.ResultsThree themes emerged across sites and disciplines (1): healthcare payers substantially shape preventative cardiovascular care in HIV clinics (2); physician compensation tied to relative value units disincentivizes cardiovascular disease prevention efforts by HIV providers; and (3) grant-based services enable tailored cardiovascular disease prevention, but sustainability is limited by sponsor priorities.ConclusionsWith HIV now a chronic disease, there is a growing need for HIV-specific cardiovascular disease prevention; however, healthcare financing complicates effective delivery of this preventative care. It is important to understand the effects of evolving payer models on patient and healthcare provider behavior. Additional systematic investigation of these models will help HIV specialty clinics implement cardiovascular disease prevention within a dynamic reimbursement landscape.Trial registrationClinical Trial Registration Number: NCT03643705.

Report this publication

Statistics

Seen <100 times